Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > Early exercise helps avoid shoulder problems after breast cancer treatment
  • News

Early exercise helps avoid shoulder problems after breast cancer treatment

  • 10 December 2021
  • Janet Fricker
Arm exercise after breast cancer
Early exercise helps avoid shoulder problems after breast cancer treatment
Total
0
Shares
0
0
0
0
0

Introducing a physiotherapy-led exercise programme following treatment for breast cancer reduces upper limb disability. The UK study, published in The British Medical Journal (online 11 November), found no increase in complications, lymphoedema or adverse events for patients allocated exercise.

“Our manualised exercise intervention is suitable for wider implementation in clinical practice,” write the authors, led by Julie Bruce, from the University of Warwick, Coventry, UK. The trial provides “the best quality evidence to date in support of prescription of early exercise for women at high risk of shoulder problems and upper limb morbidity after non-reconstructive breast cancer treatment,” they say.

Up to one third of women undergoing surgery and radiotherapy for breast cancer experience restricted range of shoulder motion, chronic pain and lymphoedema that have the effect of limiting quality of life and delaying recovery. While UK guidelines for non-reconstructive breast surgery recommend gradual reintroduction of upper limb mobility and referral to physiotherapy if problems develop, concerns have been raised that early or overly vigorous exercise might increase postoperative wound complications and lymphoedema. Systematic reviews have highlighted the lack of high-quality evidence on the timing, safety and optimal content of postoperative exercise after non-reconstructive breast cancer surgery.

The UK Prevention of Shoulder Problems trial set out to investigate the effects of an exercise programme compared with best practice usual care for women at high risk of upper limb disability after breast cancer treatment. For the study, which took place in 17 UK National Health Service Cancer Centres between January 2016 and July 2017, 392 women undergoing breast cancer surgery, at risk of postoperative upper limb morbidity, were randomised 1:1 to usual care with structured exercise (n=196) or usual care alone (n=196). Women were defined as being at high risk if they were scheduled to undergo planned axillary node clearance or to have planned radiotherapy to the axilla or supraclavicular fossa, had a body mass index ≥30, had existing shoulder problems, had any subsequent axillary surgery after sentinel node biopsy or had supraclavicular radiotherapy within six weeks of primary surgery.

The exercise programme, introduced 7-10 days post-surgery, involved referral to physiotherapy for a supervised, structured, exercise programme including stretching, strengthening, physical activity and behavioural change techniques to support adherence to exercise, while usual care involved written information about postoperative exercises and generic postoperative advice. “The aim of the intervention was to restore range of movement in the shoulder, improve strength, and increase physical activity,” write the authors. The National Institute for Health Research (NIHR)-sponsored trial trained 44 physiotherapists to deliver the intervention, which also involved two further appointments at one and three months. Participants were asked to gradually increase their physical activity with the aim of undertaking 150 minutes of moderate intensity activity per week. Although the nature of the exercise intervention meant that it was impossible to blind participants and physiotherapists, senior research team members were blinded to the treatment allocation for the duration of the trial, and a statistician independent of the core trial team did the final analysis.

Results showed the primary outcome, upper limb function assessed 12 months after randomisation using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, was 16.3 for the exercise group versus 23.7 for the usual care group (P=0.0001). Additionally, at 12 months patients undergoing exercise had lower pain intensity (16% for the exercise group vs 31% for usual care, P=0.001), fewer arm disability symptoms (P=0.001), and no increase in complications, lymphoedema or adverse events. On average the exercise programme cost an additional £129 (€152) per participant which is an affordable price for the system.

“The study provides evidence that a physiotherapy led exercise programme can be implemented at low cost. It is also associated with lower overall healthcare and personal social service costs and improves health-related quality of life compared to usual care,” says Stavros Petrou, a co-author of the study from the Nuffield Department of Primary Care at the University of Oxford.

Future research directions, write the authors, could evaluate whether the preoperative screening criteria work to identify women at higher risk of developing post-treatment limb-related disability who would benefit from the exercise programme.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • arm disability
  • breast cancer
  • lymphoedema
  • physiotherapy
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
Antihistamine checkpoint cancer
  • News

Antihistamines could improve efficacy of checkpoint inhibitors

  • 9 December 2021
  • Janet Fricker
View Post
Next Article
Liver cancer and Elpa
  • Voices

Liver patient advocates to Europe’s cancer community: can we talk?

  • 10 December 2021
  • Marko Korenjak
View Post
You May Also Like
View Post
  • News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

  • Yeva Margaryan
  • 8 May 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in April: Oncology’s Top Moments

  • Yeva Margaryan
  • 7 May 2025
View Post
  • News

CancerWorld #102 (April 2025)

  • Yeva Margaryan
  • 22 April 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in March: Oncology’s Top Moments

  • Yeva Margaryan
  • 8 April 2025
View Post
  • News

Ovarian cancer: mechanism conferring resistance to immunotherapy revealed

  • Janet Fricker
  • 21 March 2025
View Post
  • News

Muscular strength and cardiorespiratory fitness improve survival in cancer patients

  • Janet Fricker
  • 20 March 2025
View Post
  • News

CancerWorld #101 (February 2025): The Must-Read Oncology Issue Returns to Print with Exclusive Interviews and Breakthroughs

  • Yeva Margaryan
  • 18 March 2025
View Post
  • News

Low-dose aspirin reduces colorectal cancer recurrence in patients with PI3K alterations

  • Janet Fricker
  • 6 March 2025
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
  • Ovarian cancer: mechanism conferring resistance to immunotherapy revealed
    • 21 March 2025
Article
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • Istanbul, Ankara take action on HPV vaccination, as government delays promised national programme
    • 1 April 2025
  • Could this dual approach be the frontier that finally gets immunotherapy to work for MSS colorectal cancer?
    • 31 March 2025
Social

Would you follow us ?

Contents
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
  • “I really care about people.” – Philip Kantoff, A Life in Science and Medicine
    • 5 May 2025
  • What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
    • 23 April 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.